| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks | Chief Legal Officer
1 company
Eizen Joshua M is a See Remarks at AN2 Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 4 sells.
Estimated insider holdings value: $954K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 6, 2026 | ANTX An2 Therapeutics, Inc. | See Remarks | Sell | 24,854 | $1.00 | $24,962.26 | -7.4% | +215.0% | - | |
| Nov 4, 2025 | ANTX An2 Therapeutics, Inc. | See Remarks | Sell | 2,819 | $1.14 | $3,213.66 | -1.6% | -1.8% | - | |
| Jan 3, 2025 | ANTX An2 Therapeutics, Inc. | See Remarks | Sell | 9,663 | $1.34 | $12,958.08 | -7.6% | -1.4% | -21.8% |